Key Takeaways DexCom received a warning letter from the Food and Drug Administration following inspections of two of its plants.The maker of glucose monitoring devices said investigations of its San Diego,

Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous glucose monitor maker’s facilities last year. | Dexcom has received a warning letter from the FDA,

The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek clearance for new products.